Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women
- 1 June 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9321) , 1919-1920
- https://doi.org/10.1016/s0140-6736(02)08740-8
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: Significance of Pregnancy Associated Activated Protein C ResistanceThrombosis and Haemostasis, 2001
- Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancyBlood Reviews, 1999
- Thrombosis in pregnancy: maternal and fetal issuesThe Lancet, 1999
- Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)BMJ, 1997